Paper68440
Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment.
Constantinides PG and 2 others. Nature, 1977. Cited by 281 papers, by iCite.
Cite this record
ConductScience Library. Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment. Papers, record 68440. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/68440
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Azacitidine | Major topic |
| Cell Differentiation | Major topic |
| Muscles | Major topic |
| Acetylcholine | |
| Cell Line | |
| Cell Survival | |
| Dose-Response Relationship, Drug | |
| Muscle Contraction | |
| Structure-Activity Relationship |
Source PubMed
Cited by107
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 281 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41146328 | TET exhibits enzymatic-independent and-dependent functions during Drosophila flight muscle development and aging. | Skelet Muscle | 2025 | https://conductscience.org/library/papers/41146328 | PubMed |
| 40565684 | Fin Cells as a Promising Seed Cell Source for Sustainable Fish Meat Cultivation. | Foods | 2025 | https://conductscience.org/library/papers/40565684 | PubMed |
| 37854355 | The history of oral decitabine/cedazuridine and its potential role in acute myeloid leukemia. | Ther Adv Hematol | 2023 | https://conductscience.org/library/papers/37854355 | PubMed |
| 37107631 | An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review. | Genes (Basel) | 2023 | https://conductscience.org/library/papers/37107631 | PubMed |
| 37045940 | DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors. | Sci Rep | 2023 | https://conductscience.org/library/papers/37045940 | PubMed |
| 36984613 | Mass Spectrometry Contribution to Pediatric Cancers Research. | Medicina (Kaunas) | 2023 | https://conductscience.org/library/papers/36984613 | PubMed |
| 36350512 | Pathways of DNA Demethylation. | Adv Exp Med Biol | 2022 | https://conductscience.org/library/papers/36350512 | PubMed |
| 35846373 | The Art of Reprogramming for Regenerative Medicine. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/35846373 | PubMed |
| 35672334 | 5-Azacytidine increases tanshinone production in Salvia miltiorrhiza hairy roots through epigenetic modulation. | Sci Rep | 2022 | https://conductscience.org/library/papers/35672334 | PubMed |
| 35393412 | Skeletal muscle differentiation of human iPSCs meets bioengineering strategies: perspectives and challenges. | NPJ Regen Med | 2022 | https://conductscience.org/library/papers/35393412 | PubMed |
| 34790902 | Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia. | Nat Cancer | 2021 | https://conductscience.org/library/papers/34790902 | PubMed |
| 34668236 | Role of epigenetics in cellular reprogramming; from iPSCs to disease modeling and cell therapy. | J Cell Biochem | 2022 | https://conductscience.org/library/papers/34668236 | PubMed |
| 34510713 | Simple derivation of skeletal muscle from human pluripotent stem cells using temperature-sensitive Sendai virus vector. | J Cell Mol Med | 2021 | https://conductscience.org/library/papers/34510713 | PubMed |
| 33837369 | Transcriptional networks controlling stromal cell differentiation. | Nat Rev Mol Cell Biol | 2021 | https://conductscience.org/library/papers/33837369 | PubMed |
| 33796823 | Resistance to venetoclax and hypomethylating agents in acute myeloid leukemia. | Cancer Drug Resist | 2021 | https://conductscience.org/library/papers/33796823 | PubMed |
| 33737730 | Skeletal muscle regeneration via the chemical induction and expansion of myogenic stem cells in situ or in vitro. | Nat Biomed Eng | 2021 | https://conductscience.org/library/papers/33737730 | PubMed |
| 33396941 | Molecular Mechanisms Regulating Muscle Plasticity in Fish. | Animals (Basel) | 2020 | https://conductscience.org/library/papers/33396941 | PubMed |
| 33299474 | Adding a dimension to cell fate. | Anim Reprod | 2020 | https://conductscience.org/library/papers/33299474 | PubMed |
| 31419653 | Engineered skeletal muscles for disease modeling and drug discovery. | Biomaterials | 2019 | https://conductscience.org/library/papers/31419653 | PubMed |
| 31301002 | Master control: transcriptional regulation of mammalian Myod. | J Muscle Res Cell Motil | 2019 | https://conductscience.org/library/papers/31301002 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/68440
GET https://conductscience.org/api/papers/v1/68440/cited_by?page=2